High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.
about
Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancerCirculating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinomaEffects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trialSerum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis.miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesionsThe Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells.Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer.The role of Dickkopf family in cancers: from Bench to Bedside.Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases.In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls.WNT signalling in prostate cancer.
P2860
Q26745556-0B71A61D-D066-437D-8A4B-C36CF050D5C6Q27853142-B25B8A89-B7FA-4539-BEC8-BDFE86CDDB80Q28080175-5537BB0C-0D2C-45DF-8811-9BF16F50DA7CQ29248172-AA9375E3-047E-4946-847E-3598043109B7Q36212791-5D12B1D3-F7A3-4CF4-BD5D-E9DF4AF14EA5Q36916412-D4EE8117-05C5-4F9C-916A-BF1989D00EEFQ37205581-F98CAFEA-512A-4026-9656-A64130A27E92Q38682748-7C10A62B-4B7F-499C-B8AE-3E3C7DE10A6CQ38791188-E6E21298-DA6B-4F81-A2D3-BC1DBEADD865Q38823772-CB7603B9-4ABD-4464-924B-37CE0FF34A12Q39345895-43D476D0-E14D-4489-A926-8D296D5C3990Q41144323-7B93682D-D263-45DB-ABC4-9D4CF816DCAAQ42367897-5C26589C-F552-4559-916D-A1D89AB03FFBQ43968771-9E33AEDA-7A6B-4B50-A5F0-9CE8F99B81EAQ47723896-1F8A1EC3-914A-41B8-A70F-A7594B0D4C74Q47818549-0599E300-9D8C-40F7-BC24-04F522F58033
P2860
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@ast
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@en
type
label
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@ast
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@en
prefLabel
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@ast
High serum levels of Dickkopf- ...... s in prostate cancer patients.
@en
P2093
P2860
P356
P1433
P1476
High serum levels of Dickkopf- ...... is in prostate cancer patients
@en
P2093
Andrew Browne
Andy Göbel
Kati Erdmann
Manfred P Wirth
Martina Rauner
Matthias Kieslinger
Michael Fröhner
Michael H Muders
Stefanie Thiele
Susanne Fuessel
P2860
P2888
P356
10.1186/1471-2407-14-649
P407
P577
2014-09-02T00:00:00Z
P5875
P6179
1031689479